Mast Therapeutics, Inc. (NYSE: MSTX) 39.8% LOWER; today announced the pricing of an underwritten public offering of 29,090,910 units at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Jefferies Raises Price Target on Panera Bread (PNRA) to $195; Says Turnaround Continues to Take Shape February 11, 2016 9:37 AM Needham & Company Reiterates Buy as Radisys Corp's (RSYS) 4Q Results Come In-Line with Preannouncement February 10, 2016 2:14 PM